In the present study, ALDOA expression at both the mRNA and the protein levels was significantly increased and decreased in parallel with overexpression and knockdown of ANGPTL4 in melanoma cells, which was blocked by selective PKC inhibitor and restored by PKC agonist, respectively. Here, ANGPTL4 is linked to melanoma.